MEDICENNA REPORTS POTENT CD122 BLOCKADE AND EXTENDED SURVIVAL WITH MDNA209 IN PRECLINICAL MODELS OF AUTOIMMUNE DISEASE

Reuters · 1d ago

Please log in to view news